Higher Estrogen Levels Are Not Associated With Larger Hippocampi and Better Memory Performance
Authors:
- Mirjam I. GeerlingsMGMirjam I. Geerlings
- Albert HofmanAHAlbert Hofman
- Frank H. de JongFJFrank H. de Jong
- Lenore J. LaunerLLLenore J. Launer
- Huibert A. P. PolsHPHuibert A. P. Pols
- Monique M. B. BretelerMBMonique M. B. Breteler
Open Access
- 1 February 2003
- journal article
- research article
- Published by American Medical Association (AMA) in Archives of Neurology
- Vol. 60 (2) , 213-220
Abstract
AFTER MENOPAUSE, women have low levels of circulating estrogens. Observational studies reported a reduced risk of cognitive decline and Alzheimer disease (AD) in postmenopausal women using estrogen replacement therapy.1,2 In animals, estrogens protect hippocampal neurons exposed to amyloid β,3 improve synapse formation on dendritic spines in the hippocampus,4 and promote survival of hippocampal neurons, acting in concert with growth factors.5 Estrogen receptors are located throughout the brain, but especially in the hippocampus.6 Given the beneficial effects of estrogens on the hippocampus in animals, it has been hypothesized that estrogens may prevent hippocampal atrophy, a key feature of AD.7 The hippocampus plays a pivotal role in memory function and is one of the first regions affected in AD.8 The aim of this study was to investigate whether higher endogenous levels of estradiol were associated with larger hippocampal volumes on magnetic resonance imaging (MRI) and better memory performance. We examined this hypothesis in a population-based study of older women and men who did not have dementia.Keywords
This publication has 25 references indexed in Scilit:
- The Human Brain Has Distinct Regional Expression Patterns of Estrogen Receptor α mRNA Isoforms Derived from Alternative PromotersJournal of Neurochemistry, 2000
- Vascular Involvement in Cognitive Decline and Dementia: Epidemiologic Evidence from the Rotterdam Study and the Rotterdam Scan StudyAnnals of the New York Academy of Sciences, 2000
- Memory and MRI-based hippocampal volumes in aging and ADNeurology, 2000
- Estradiol Increases Dendritic Spine Density by Reducing GABA Neurotransmission in Hippocampal NeuronsJournal of Neuroscience, 1998
- Neuroprotection against Oxidative Stress by Estrogens: Structure-Activity RelationshipMolecular Pharmacology, 1997
- Specific Hippocampal Volume Reductions in Individuals at Risk for Alzheimer’s DiseaseNeurobiology of Aging, 1997
- S43 P06.022-a prospective study of estrogen replacement therapy and the risk of developing alzheimer's disease in the baltimore longitudinal study of agingMaturitas, 1996
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Determinants of disease and disability in the elderly: The Rotterdam elderly studyEuropean Journal of Epidemiology, 1991
- Learning and Retrieval Rate of Words Presented Auditorily and VisuallyThe Journal of General Psychology, 1985